Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial (Q38374620)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial (English)

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

Janusz Gumprecht

4

object named as

Janusz Gumprecht

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

author name string

Wendy Lane

1

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Timothy S Bailey

2

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Gregg Gerety

3

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Athena Philis-Tsimikas

5

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Charlotte Thim Hansen

6

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Thor S S Nielsen

7

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Mark Warren

8

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Group Information

9

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

SWITCH 1

10

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

language of work or name

0 references

publication date

1 July 2017

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

The Journal of the American Medical Association

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

318

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

1

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

33-44

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Increased mortality of patients with diabetes reporting severe hypoglycemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority tria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

23 June 2018

Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

31 August 2018

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

31 August 2018

Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

31 August 2018

Severe hypoglycemia and risks of vascular events and death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

31 August 2018

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

31 August 2018

Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5817477

3 December 2018

Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28672316

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/JAMA.2017.7115

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5817477

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38374620&oldid=1756592495"